[Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
D000208:Acute Disease; D001419:Bacteria / Q000187:drug effects*; D001798:Blood Proteins; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D009343:Neisseria / Q000187:drug effects; D011485:Protein Binding; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use*; D013183:Sputum / Q000032:analysis; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D001798:Blood Proteins; D012293:Rifampin
Der Wert des Rifampicin bei der Behandlung von Patienten mit bronchopulmon-ären Affektionen. Eine klinisch-bakteriologische Studie.